Detalles de la búsqueda
1.
Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort.
Proc Natl Acad Sci U S A
; 113(21): E3002-11, 2016 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-27162351
2.
Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes.
Cardiovasc Diabetol
; 15: 30, 2016 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-26864236
3.
The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes.
Glycoconj J
; 33(4): 569-79, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27342131
4.
Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
Cardiovasc Diabetol
; 14: 118, 2015 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26341632
5.
Rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Circulation
; 128(8): 785-94, 2013 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23857320
6.
Long-term effects of intensive glucose lowering on cardiovascular outcomes.
N Engl J Med
; 364(9): 818-28, 2011 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-21366473
7.
The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study.
Ophthalmology
; 121(12): 2443-51, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25172198
8.
Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications.
Clin Chem Lab Med
; 52(1): 21-32, 2014 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23787467
9.
Effects of medical therapies on retinopathy progression in type 2 diabetes.
N Engl J Med
; 363(3): 233-44, 2010 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20587587
10.
Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
Circulation
; 124(6): 695-703, 2011 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-21768545
11.
Myocardial structure, function, and scar in patients with type 1 diabetes mellitus.
Circulation
; 124(16): 1737-46, 2011 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-21947298
12.
Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients.
Kidney Int
; 81(6): 586-94, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22166848
13.
A randomized trial of therapies for type 2 diabetes and coronary artery disease.
N Engl J Med
; 360(24): 2503-15, 2009 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-19502645
14.
Evolution of the study coordinator role: the 28-year experience in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).
Clin Trials
; 9(4): 418-25, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22729476
15.
Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials.
Ann Intern Med
; 154(8): 554-9, 2011 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-21502652
16.
Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT/EDIC.
BMJ Open Diabetes Res Care
; 10(1)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35058313
17.
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.
Lancet
; 376(9739): 419-30, 2010 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-20594588
18.
Effects of intensive glucose lowering in type 2 diabetes.
N Engl J Med
; 358(24): 2545-59, 2008 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-18539917
19.
Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial".
Circulation
; 129(16): e460-1, 2014 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-24753557
20.
Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT).
Am J Kidney Dis
; 55(5): 824-34, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20138413